Prediction of early treatment failure of second-line nal-iri/5-FU/FA in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216).
Meinolf Karthaus, Nikolaus Ansorge, Gleb Barmashenko, Christof Burkart,Thomas Decker,Thomas Jens Ettrich, Anke Gerhardt, Sabine Hoefling,Lutz Jacobasch,Michael Koenigsmann, Sebastian Rath, Markos Schulte, Nadine Schulte, Andreas Schwarzer,Gabriele Margareta Siegler,Dirk Waldschmidt, Manfred P. Lutz JOURNAL OF CLINICAL ONCOLOGY（2023）
AI 理解论文
溯源树
样例
